- Home
- ZURA vs ABSI Comparison
ZURA vs ABSI Comparison
Compare ZURA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | ABSI |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | 30 | 157 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.0M | 357.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZURA | ABSI |
|---|---|---|
| Price | $6.93 | $2.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $11.78 | $7.98 |
| AVG Volume (30 Days) | 482.1K | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $2.01 |
| 52 Week High | $7.19 | $5.23 |
Technical Indicators
Market Signals| Indicator | ZURA | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 37.19 |
| Support Level | $5.62 | N/A |
| Resistance Level | N/A | $3.29 |
| Average True Range (ATR) | 0.50 | 0.17 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 80.14 | 2.94 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.